Scientists aim to gather knowledge that improves future immunotherapies
July 30, 2018
| By Susan Keown / Fred Hutch News Service
The immune system has the potential to eradicate cancer. But cancers are expert escape artists, with numerous tools for shutting down or hiding from immune attack. Three research teams at Fred Hutch have launched new projects aimed at revealing some of these secrets and laying the groundwork for developing better immune-harnessing cancer therapies, or immunotherapies.
Immunotherapy a key topic at sold-out discussion on the role of biotech in Seattle
May 7, 2015
| By Bill Briggs / Fred Hutch News Service
The word “cure” has long been overused, but the promise of immunotherapy as an anti-cancer weapon means it’s indeed the right time to start using it, said Dr. D. Gary Gilliland, president and director of Fred Hutch, at an Xconomy Forum held at the Hutch on Wednesday.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.